- Home
- TRDA vs NAT Comparison
TRDA vs NAT Comparison
Compare TRDA & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- NAT
- Stock Information
- Founded
- TRDA 2016
- NAT 1995
- Country
- TRDA United States
- NAT Bermuda
- Employees
- TRDA N/A
- NAT N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- NAT Marine Transportation
- Sector
- TRDA Health Care
- NAT Consumer Discretionary
- Exchange
- TRDA Nasdaq
- NAT Nasdaq
- Market Cap
- TRDA 609.7M
- NAT 641.0M
- IPO Year
- TRDA 2021
- NAT 1997
- Fundamental
- Price
- TRDA $17.85
- NAT $2.98
- Analyst Decision
- TRDA Strong Buy
- NAT Hold
- Analyst Count
- TRDA 3
- NAT 2
- Target Price
- TRDA $23.33
- NAT $3.75
- AVG Volume (30 Days)
- TRDA 132.5K
- NAT 2.7M
- Earning Date
- TRDA 11-05-2024
- NAT 11-27-2024
- Dividend Yield
- TRDA N/A
- NAT 16.11%
- EPS Growth
- TRDA N/A
- NAT N/A
- EPS
- TRDA 1.55
- NAT 0.29
- Revenue
- TRDA $215,232,000.00
- NAT $364,249,000.00
- Revenue This Year
- TRDA $47.63
- NAT N/A
- Revenue Next Year
- TRDA N/A
- NAT $11.06
- P/E Ratio
- TRDA $11.51
- NAT $10.27
- Revenue Growth
- TRDA 146.92
- NAT N/A
- 52 Week Low
- TRDA $10.75
- NAT $2.95
- 52 Week High
- TRDA $20.49
- NAT $4.64
- Technical
- Relative Strength Index (RSI)
- TRDA 48.42
- NAT 30.59
- Support Level
- TRDA $19.28
- NAT $2.95
- Resistance Level
- TRDA $20.49
- NAT $3.12
- Average True Range (ATR)
- TRDA 0.92
- NAT 0.10
- MACD
- TRDA -0.01
- NAT -0.01
- Stochastic Oscillator
- TRDA 25.21
- NAT 6.10
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters pursuant to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.